What we offer
Questions we can answer
If your project is raising any of the following questions, there’s a very good chance that our team can get you the answers you need.
Whether your project is academic or pre-commercial, we can help you drive it towards commercialisation. We can offer guidance on your future customers’ needs, honing your plans and your data package to maximise their coherence and credibility, helping you make your project more attractive to investors.
With our many decades of discovery experience, we can advise on what is needed to progress your molecule and we can help you to develop and implement a strategy to generate this data and understanding.
We can help you evaluate your lead molecule in cutting edge in-vitro and in-vivo human cell models to build confidence in your asset as you progress towards the clinic.
We can deploy our suite of analytical technologies to build a platform of evidence connecting your drug, its biological target, and downstream effects. These assays can then be deployed to support project progression.
We can use our advanced technologies to measure the distribution of your drug molecule or drug delivery technology in-vivo to demonstrate that it reaches its target tissue, then delve deeper to measure the distribution of the drug molecule within the tissue and its downstream effects.
We can help you to identify and measure translatable biomarkers that can be applied to demonstrate that your drug is exhibiting its desired effect at each stage of your project journey and help to understand which patients could benefit from your drug.
We are committed to supporting the progression of new technologies and approaches that are relevant to drug discovery. Whether a novel method or a new technology, we can help you validate and benchmark your platform in a drug discovery environment and develop new applications that can grow your business.
We use predictive models and data-driven analytics to predict druggability from a raw dataset or a candidate list of targets, and then select the most likely successful therapeutic modality class for these. Thereby mitigating risks; saving time and money; streamlining decision-making; increasing the chances of success, and getting your drug to market quicker.
Our predictive models and data-driven analytics can go a long way to detailing the efficacy and safety of a new medicine, before a single test on animal or human takes place.
Finding an alternative use – or uses – for an existing medicine can be hugely beneficial. With its testing and safety compliance already in place, a drug can be sped to market at minimum cost. By cross-referencing a drug’s composition and effects with very large amounts of research data, new opportunities can present themselves.
People suffering from complex or multifaceted issues often benefit from combinations of drugs, which can work to increase efficacy, overcome resistance and reduce adverse reactions. Through the close analysis of extremely large amounts of data, we can find opportunities for your drug to work in harmony with others.
Chemical space is vast, and only a fraction of it has been explored in terms of drug discovery. Through virtual screening and in-depth analysis of bioactivities, we can identify potential lead compounds for you, at speed and with confidence.